Statement of changes in beneficial ownership of securities



>




X0306


4


2021-06-03


0



0001624658


Allena Pharmaceuticals, Inc.


ALNA





0001276038


SANTINI GINO




C/O ALLENA PHARMACEUTICALS, INC.


ONE NEWTON EXECUTIVE PARK, SUITE 202


NEWTON


MA


02462






1


0


0


0







Stock Option (Right to Buy)




1.14




2021-06-03






4


A


0









37000




0.00




A









2031-06-02





Common Stock




37000






37000






D







Stock option shall vest in full (i.e., in single installment) upon the earlier to occur of the first anniversary of the date of grant or the date of the next annual meeting of stockholders.






/s/ Kevin Brennan, attorney-in-fact


2021-06-04





The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Allena Pharmaceuticals, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

Statement of acquisition of beneficial ownership by individuals - Jan. 25, 2022
Allena Pharmaceuticals Provides Clinical And Corporate Update ALLN-346, - Jan. 4, 2022

Auto Refresh

Feedback